Gerresheimer AG buy papaver
Summary
This prediction ended on 18.01.17 with a price of €75.19. The prediction had a final performance of 11.89%. papaver has 50% into this predictionGerresheimer is a German-based company that specializes in the production of high-quality glass and plastic packaging solutions for the healthcare industry. The company's products are used to store and transport medicines, vaccinations, and other healthcare products. With a global footprint, Gerresheimer operates in Europe, North America, South America, and Asia, serving leading pharmaceutical and life science companies. The company is publicly traded on the Frankfurt Stock Exchange and has a strong reputation for innovation, quality, and sustainability.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gerresheimer AG | 2.554% | 2.554% | -13.820% | 11.929% |
iShares Core DAX® | 2.147% | 2.681% | 17.410% | 16.694% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% | 34.957% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% | 11.023% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% | 37.315% |
Comments by papaver for this prediction
In the thread Gerresheimer AG diskutieren
PHARMAAKTIEN IM AUFWIND
Nach einem Kursrücksetzer gibt es nun gute Chancen auf Erholung.